PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Novartis- Amgen and Banner Alzheimer's Institute Terminate Two P-II/III Studies of CNP520 (umibecestat) for the Prevention of Alzheimer's Disease

Novartis- Amgen and Banner Alzheimer's Institute Terminate Two P-II/III Studies of CNP520 (umibecestat) for the Prevention of Alzh...

July 12, 2019

Abbott's Alinity S System Receives FDA's Approval for Blood and Plasma Screening in the US

Abbott's Alinity S System Receives FDA's Approval for Blood and Plasma Screening in the US

July 12, 2019

Ono Pharmaceutical Signs an Exclusive License Agreement with Forty Seven to Develop and Commercialize 5F9 in Selected Asian Countries

Ono Pharmaceutical Signs an Exclusive License Agreement with Forty Seven to Develop and Commercialize 5F9 in Selected Asian Countr...

July 12, 2019

Valeo Launches Onstryv (safinamide tablet) for the Treatment of Parkinson's Disease in Canada

Valeo Launches Onstryv (safinamide tablet) for the Treatment of Parkinson's Disease in Canada

July 12, 2019

Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in Three P-III Studies for Chronic and Episodic Migraine

Eli Lilly Reports Results of Emgality (galcanezumab-gnlm) in Three P-III Studies for Chronic and Episodic Migraine

July 12, 2019

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us